Gianfranco Spalletta Selected Research

tramiprosate

1/2022	IL-33 and IL-10 Serum Levels Increase in MCI Patients Following Homotaurine Treatment.
1/2018	Anti-inflammatory Effects of Homotaurine in Patients With Amnestic Mild Cognitive Impairment.
1/2016	Homotaurine Effects on Hippocampal Volume Loss and Episodic Memory in Amnestic Mild Cognitive Impairment.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gianfranco Spalletta Research Topics

Disease

36	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 06/2005
18	Schizophrenia (Dementia Praecox) 11/2023 - 01/2003
18	Cognitive Dysfunction 04/2022 - 04/2003
13	Parkinson Disease (Parkinson's Disease) 01/2023 - 01/2010
12	Stroke (Strokes) 01/2013 - 04/2003
7	Mental Disorders (Mental Disorder) 08/2021 - 05/2005
6	Dementia (Dementias) 01/2018 - 05/2008
5	Inflammation (Inflammations) 01/2022 - 02/2013
5	Atrophy 01/2016 - 10/2009
4	Neuroinflammatory Diseases 01/2022 - 08/2007
4	Bipolar Disorder (Manic Depressive Psychosis) 01/2022 - 01/2016
4	Disease Progression 01/2016 - 01/2013
3	Neoplasms (Cancer) 09/2022 - 02/2008
3	Obsessive-Compulsive Disorder (Disorder, Obsessive-Compulsive) 01/2022 - 01/2015
3	Major Depressive Disorder (Major Depressive Disorders) 01/2022 - 10/2003
2	Parkinsonian Disorders (Parkinsonism) 01/2022 - 01/2020
2	Pain (Aches) 01/2022 - 09/2010
2	COVID-19 08/2020 - 01/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2018 - 01/2015
2	Agnosia (Visual Agnosia) 01/2018 - 12/2010
2	Mood Disorders (Mood Disorder) 01/2016 - 02/2008
2	Anhedonia 01/2016 - 08/2011
2	Depressive Disorder (Melancholia) 01/2013 - 01/2010
2	Psychotic Disorders (Schizoaffective Disorder) 07/2010 - 01/2009
1	Brain Neoplasms (Brain Tumor) 09/2022
1	22q11 Deletion Syndrome 01/2022
1	Traumatic Brain Injuries (Traumatic Brain Injury) 01/2022
1	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 01/2022
1	Genetic Risk Score 01/2021
1	Cardiovascular Diseases (Cardiovascular Disease) 01/2019
1	Obesity 01/2019

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 01/2022 - 08/2007
9	Antidepressive Agents (Antidepressants)IBA 01/2020 - 04/2003
8	Interleukin-18 (Interleukin 18)IBA 01/2022 - 08/2007
8	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2003
7	Apolipoproteins E (ApoE)IBA 01/2022 - 01/2010
6	Amyloid (Amyloid Fibrils)IBA 04/2022 - 01/2012
5	Biomarkers (Surrogate Marker)IBA 11/2023 - 01/2015
5	ApolipoproteinsIBA 01/2019 - 06/2005
4	InterleukinsIBA 08/2015 - 08/2007
4	Brain-Derived Neurotrophic Factor (BDNF)IBA 08/2013 - 02/2010
3	LipidsIBA 01/2022 - 01/2019
3	tramiprosateIBA 01/2022 - 01/2016
3	gamma-Aminobutyric Acid (GABA)IBA 12/2020 - 01/2005
3	LithiumIBA 01/2020 - 01/2016
3	Cholinesterase Inhibitors (Anticholinesterases)IBA 11/2018 - 01/2014
3	Dopamine (Intropin)FDA LinkGeneric 03/2016 - 08/2011
3	Amyloid beta-PeptidesIBA 08/2013 - 02/2009
3	Glutathione Transferase (Glutathione S-Transferase)IBA 08/2012 - 06/2005
3	Messenger RNA (mRNA)IBA 01/2012 - 01/2010
2	AcidsIBA 01/2022 - 01/2014
2	MicroRNAs (MicroRNA)IBA 01/2022 - 01/2021
2	Levodopa (L Dopa)FDA LinkGeneric 01/2021 - 10/2013
2	Carrier Proteins (Binding Protein)IBA 01/2019 - 08/2012
2	Antipsychotic Agents (Antipsychotics)IBA 11/2018 - 01/2009
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 01/2016 - 01/2014
2	Neuroprotective AgentsIBA 01/2016 - 01/2016
2	Rivastigmine (Exelon)FDA LinkGeneric 01/2014 - 07/2013
2	Interleukin-6 (Interleukin 6)IBA 01/2013 - 06/2011
2	EnzymesIBA 05/2011 - 07/2010
2	DysbindinIBA 03/2011 - 01/2010
2	Monoamine Oxidase (MAO)IBA 02/2011 - 07/2010
2	IronIBA 11/2010 - 10/2009
2	Nerve Growth Factors (Neurotrophins)IBA 07/2010 - 01/2009
2	Fluoxetine (Prozac)FDA LinkGeneric 06/2009 - 04/2003
2	NeurosteroidsIBA 05/2005 - 01/2005
2	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 10/2003 - 04/2003
2	Sertraline (Zoloft)FDA LinkGeneric 10/2003 - 04/2003
1	ethyl 4-azidophenyl-1,4-dithiobutyrimidateIBA 01/2023
1	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023
1	Angiotensin-Converting Enzyme 2IBA 01/2022
1	NeurotoxinsIBA 01/2022
1	amidaseIBA 01/2022
1	PPAR gammaIBA 01/2022
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2022
1	N-acylethanolaminesIBA 01/2022
1	palmidrolIBA 01/2022
1	Cysteine (L-Cysteine)FDA Link 01/2022
1	Interleukin-33IBA 01/2022
1	Interleukin-10 (Interleukin 10)IBA 01/2022
1	HydrolasesIBA 01/2022
1	Oxidopamine (6 Hydroxydopamine)IBA 01/2022
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 01/2022
1	Silver Sulfadiazine (SSD)FDA LinkGeneric 01/2022
1	safinamideIBA 01/2021
1	sharpinIBA 01/2021
1	Dopamine Agonists (Dopamine Agonist)IBA 01/2020
1	VaccinesIBA 01/2020
1	CeramidesIBA 01/2019
1	CholesterolIBA 01/2019
1	Estradiol (Delestrogen)FDA LinkGeneric 01/2019
1	EthanolaminesIBA 01/2019

Therapy/Procedure

11	Therapeutics 01/2019 - 11/2008
1	Transcranial Magnetic Stimulation 09/2022
1	Aftercare (After-Treatment) 01/2022
1	Precision Medicine 08/2021
1	Transcranial Direct Current Stimulation 01/2021
1	Ambulatory Care (Outpatient Care) 01/2020
1	Duration of Therapy 01/2020
1	Wearable Electronic Devices 01/2020